Qian et al. 2016 [20] has reported that the pan-mTOR kinase inhibitors MTI-31 and AZD8055 induce G0/G1 cell cycle arrest corresponding with suppression of cyclin D1 and c-Myc in HER2+/PIK3CA mutant breast cancer cells. This evidence concerns the gene ERBB2 and breast carcinoma.